SEC Form 4 · accession 0000899866-18-000078
ALEXION PHARMACEUTICALS, INC. · ALXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher J Coughlin
Director
Period of report
Apr 30, 2018
Accepted (ET)
May 2, 2018 · 5:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899866
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.0001 per share | Apr 30, 2018 | P | 10,000 | $120.79 | A | 26,333 | D |
Table II — derivative securities
No Table II lines on this filing.